Congenital Heart Disease Clinical Trials in New York, New York

5 studies are recruiting for congenital heart disease in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

   There are two primary goals of this multicenter clinical trial that combines an FDA device trial and a phase II drug trial in the same study cohort. These two goals are to: 1. To evaluate the safety and effectiveness of the Cardiohelp Device for VA-ECMO (heart-lung support) for up to 30 days of sup…

   Stage

   Phase 2

   Ages

   0 to 16

   Site

   Cuimc/Nyph, New York, New York

   Locations

   5 in total

   Run by

   Stanford University

   See if you can join NCT06080074 on ClinicalTrials.gov

2. Autus Valve Continued Access Study (CAS)

   Prospective, single-arm, multi-center, continued access study of the Autus Size-Adjustable Valve in pediatric patients aged 18 months to 16 years requiring surgical pulmonary valve replacement. The Autus Valve may be expanded pre-implant to match the subject's body size. Subjects will be evaluated …

   Stage

   Not phased

   Ages

   1 to 16

   Site

   Columbia University Irving Medical Center/New York Presbyterian Morgan Stanley Children's Hospital, New York, New York

   Locations

   10 in total

   Run by

   Edwards Lifesciences

   See if you can join NCT07466745 on ClinicalTrials.gov

3. Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)

   Recent retrospective studies have demonstrated differences between pulse oximeter values (SpO2) and measured arterial oxygen saturation (SaO2) in patients identifying as Black or Hispanic. These retrospective studies have limitations because self-reported race is likely not an accurate metric for l…

   Stage

   Not phased

   Ages

   Up to 18

   Site

   Mount Sinai Hospital, New York, New York

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT06575270 on ClinicalTrials.gov

4. Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

   This real-world, international registry aims to evaluate the current experience with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease (ACHD) patients by investigating the prescription patterns, safety, tolerability, and potential beneficial effects on heart failu…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mount Sinai Fuster Heart Hospital, New York, New York

   Locations

   11 in total

   Run by

   Leiden University Medical Center

   See if you can join NCT06932081 on ClinicalTrials.gov

5. Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment

   The purpose of this research study is to look at the advantages of using a 3D printed heart model for surgical planning in children who have been diagnosed with Congenital Heart Disease (CHD) and clinical heart failure and will undergo a ventricular assist device (VAD) placement. The investigators …

   Stage

   Not phased

   Ages

   Any age

   Site

   Columbia University, New York, New York

   Locations

   5 in total

   Run by

   Columbia University

   See if you can join NCT03891160 on ClinicalTrials.gov